SoVIRIP
SoVIRIP is a virus inhibitory peptide with an IC50 of 1.2 μM for HIV-1 . soVIRIP binds to the HIV-1 GP41 fusion peptide and inhibits viral fusion and entry into host cells. soVIRIP has broad-spectrum anti-HIV-1 activities with nontoxicity in zebrafish models. soVIRIP can used for viral infections research[1].
Product Specifications
UNSPSC
12352209
Target
HIV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(N[C@@H](CCC(O)=O)C(N[C@@H](C)C(N[C@@H]([C@@H](C)CC)C(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](C(C)C)C(N[C@@H](CC3=CC=CC=C3)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N
Molecular Formula
C56H84N10O13
Molecular Weight
1105.33
References & Citations
[1]Zech F, et al. ReaxFF-Guided Optimization of VIRIP-Based HIV-1 Entry Inhibitors. J Phys Chem B. 2025 Apr 17;129 (15) :3788-3795.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
HIV-1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA504452BM 100 µL
NPTN Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI2F5]
Sign In for Pricing
View Details 